The Future is Here: Analyzing Weil Company Q3 2022 vs. Q4 2022 Fund Holdings
Ava Hoppe | 25 April, 2023
Weil Company's Q3 2022 vs. Q4 2022 13F holdings comparison reveals significant changes in the fund's holdings. In the third quarter, the fund's total value was $90,336, while it dropped to $85,151 in the fourth quarter, a decrease of 5.7%. This change can be attributed to different factors, including market volatility, macroeconomic conditions, and specific trends in the industry. In this blog post, we will analyze the fund's holdings, including the top-performing stocks, the worst-performing stocks, and the reasoning behind these changes.
Top-performing stocks
Among the companies that showed positive changes in the fund's holdings, United Therapeutics Corp Del (UTHR) takes the lead, with an outstanding 54.5% increase in the number of shares held. The reason behind this significant increase is the company's strong performance during this period. Another company that showed an impressive increase is VanEck ETF Trust (GDX) with a 30.5% increase in shares held. This increase is due to the rise in gold prices in Q4 2022.
Worst-performing stocks
On the other hand, some companies have shown a downtrend in the fund's holdings. CVS Health Corp (CVS) leads with a -34.5% decrease in the number of shares held. This decrease can be attributed to the company's poor performance in Q4 2022. Another company that struggled is Disney Walt Co (DIS), with a -31.4% decrease in shares held, reflecting the impact of the pandemic on the entertainment industry.
Reasoning behind these changes
Aside from the performance of the individual companies, we can also look at broader macroeconomic trends to explain the changes in the fund's holdings. For instance, the 269.2% increase in iShares TR (AGG) shares can be attributed to the low-interest-rate environment, which leads to increased demand for bonds. Similarly, the 385.6% increase in SPDR S&P 500 ETF TR (SPY) shares can be linked to the overall market trend during this period, where many companies posted strong earnings reports and showed high shareholder returns.
Conclusion
Overall, Weil Company's Q3 2022 vs. Q4 2022 13F holdings comparison shows interesting changes in the fund's holdings. While some companies performed exceptionally well, others struggled, reflecting the volatility of the market, shifting macroeconomic conditions, and individual company performance. As always, investors should keep a close eye on these trends to make informed decisions and achieve their investment goals.
Other Posts
- From Meats to Millions: How a Prime Partnership is Sizzling Up the Protein Sector
- Argonaut Private Equity: Investing in Middle America and Closing Fund V at $500 Million
- Investment Advisor Deep Dive: Sterling's Q4 2022 vs. Q1 2023 13F Holdings
- Focused Wealth Management, Inc Q3 2023 vs. Q4 2023 13F Holdings Comparison
- Comparing Oakmont Corp's Q3 2022 and Q4 2022 fund holdings: A review of the biggest changes
- Redhawk Wealth Advisors, Inc. Q2 2023 vs. Q3 2023: A Detailed Comparison of 13F Holdings
- A Comparison of ThornTree Capital Partners' Q3 and Q4 2022 13F Holdings
- Analyzing Signature Estate & Investment Advisors LLC's Q3 2022 vs. Q4 2022 13F Holdings
- Crofter's Organic Appoints Tim Jax as CEO: A New Chapter for Organic Jam Giant
- Tackling the Green: How Bruin Capital's Acquisition of PlayGreen Scores Big for the Sports World